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EXPLORING THE INTERRELATIONSHIP BETWEEN UNINTENTIONAL AND
INTENTIONAL NONADHERENCE AMONG 24,071 ADULTS WITH CHRONIC
DISEASE
Gadkari A, McHorney C
Merck & Co., Inc, North Wales, PA, USA
OBJECTIVES: The objective of this study was to explore the interrelationship be-
tween intentional and unintentional non-adherence vis-à-vis patients’medication
beliefs.METHODS:We conducted a cross-sectional survey of adults with asthma,
hypertension, diabetes, hyperlipidemia, osteoporosis, or depression from the Har-
ris Chronic Disease Panel. A total of 24,071 adults self-identified themselves as
currently persistent to prescription medications for their index disease. They an-
swered three questions on unintentional non-adherence, 11 questions on inten-
tional non-adherence, and 20 questions assessing their beliefs about the index
medication, which generated multi-item scales assessing perceived medication
need (k10), perceived concerns (k6), and perceived affordability (k4).The re-
gression approach proposed by Baron and Kenny was used to test the mediational
effect of unintentional non-adherence on the relationship between medication
beliefs and intentional non-adherence. Bootstrapping was also employed to con-
firm the statistical significance of these results. RESULTS: It was hypothesized that
the effect of medication beliefs (perceived need, concerns, and affordability) on
intentional non-adherence is mediated through unintentional non-adherence.
The four conditions outlined by Barron andKenny for a variable to be considered as
a mediating variable were satisfied. The three medication beliefs had a significant
direct effect on unintentional non-adherence. The direct effect of unintentional
non-adherence on intentional non-adherence was significant as was the total ef-
fect ofmedication beliefs on intentional non-adherence. The impact ofmedication
beliefs on intentional non-adherence was reduced after controlling for uninten-
tional non-adherence. The statistical significance of the mediational relationship
was confirmed using the bootstrapping procedure with 5,000 samples.
CONCLUSIONS: Unintentional non-adherence may appear to be a rather benign
behavior; however, its importance may lie in its potential prognostic significance
for future intentional non-adherence. Hence, health care providers should screen
for unintentional non-adherence in patients while they are still on therapy and
proactively address suboptimal medication beliefs that might ultimately lead the
patient to discontinue therapy.
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PSYCHOMETRIC COMPARIBILITY OF SINGLE ITEM AND GRID FORM
ADMINISTRATION OF THE SF-36V2™ HEALTH SURVEY
Smith KJ, Kosinski M
QualityMetric Incorporated, Lincoln, RI, USA
OBJECTIVES: Over the past two decades use of the traditional paper-and-pencil
survey has waned as options for electronic data collection have been shown to be
rigorous andmore cost-effective. Although research supports equivalence of paper
and electronic administration modes, evidence examining the impact of changes
in item form required to accommodate small format electronic devices is lacking.
This study examined the impact of a single item (SI) presentation versus grid dis-
play (GD) for score equivalence, measurement properties and adherence to the
conceptual framework of the SF-36v2.METHODS:The SF-36v2 standard recall form
was electronically presented as part of a US national norming study. Survey results
from SI (N2037) and GD (N2003) administrations were then scored. ANCOVA
models compared SI and GD scale scores. A Multi-trait Analysis Program (MAPR)
and principal components analysis (PCA) were used to examine the measurement
properties and test the conceptual framework of SI and GD data. RESULTS: Mean
score comparisons revealed small differences between SI and GD on seven scales
(all p 0.01). Mean differences (.43 to 1.42), however, failed to reach the minimally
important difference of 3 points indicating relative equivalence. MAP-R analyses
showed that, for both item formats, SF-36v2 items had excellent convergent valid-
ity with their hypothesized scale (r0.4) and each item correlated higher with its
hypothesized scale than with others (divergent validity). PCA results showed that
the hypothesized two-dimensional structure of physical and mental health was
evident in both formats as the pattern of correlation between scales and principal
components was consistent with a priori hypotheses and the two components
explained the majority of variance in the eight scales (75%). CONCLUSIONS: Sin-
gle item presentation, which separates items from the contextual cues of their
traditional grid format, results in scores and measurement properties consistent
with GD, and maintains the underlying conceptual framework of the SF-36v2.
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IMPACT OF A WEB PORTAL TOOL ON DRIVING PATIENT ADHERENCE
Ying X, Khandelwal N, Korcheck R, Duncan I
Walgreens, Deerfield, IL, USA
OBJECTIVES: To determine the value of a web portal by quantifying the differences
in medication adherence between web-users and non-web-users. METHODS: A
case-control study designwas employed for this study. Prescription records from a
de-identified pharmacy claims database maintained by a large pharmacy benefit
manager were obtained between April 1st 2009 to March 31st 2010. The test group
consisted of patients who filled their prescriptions via a web-based portal. Patients
whowere enrolled in similar health plans but never used the web portal to fill their
prescriptions comprised the control group. All eligible patients included in this
analysis were continuously enrolled during the study period. Differences in med-
ication possession ratio (MPR), defined as the sum of days that patient possessed
any maintenance medication divided by the total number of days in the follow-up
period, was calculated during the observation period and compared using a paired
t-test. Additionally, MPRs for the Top 10 therapeutic medication classes were com-
puted and compared across test and control group. RESULTS: A total of 2,333,635
eligible patients were included in the study. Among them 53,018 patients met the
criteria for test group and 2,280,617 patients were included in the control group.
Overall mean MPR for the test group was found to be significantly higher (0.48 Vs
0.37) as compared to the control group (p0.05). Additionally, across all the Top 10
medication classes, the test group patients’mean MPR was significantly higher
than that of control group patients. CONCLUSIONS: Patients, who filled their pre-
scriptions via the web portal, have higher adherence rates as compared to those
who do not choose this channel to fill their scripts. Further studies aimed at eval-
uating key drivers for the differential adherence rate are required to gain additional
insights about the importance of web-portal as a tool for refilling prescriptions.
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SF-12 AND EQ-5D UTILITY SCORING STRATEGY: LESSONS FROM APPLYING 40
SCORINGS TO 3 LARGE DATA SETS
Miller TR1, Bhattacharya S2
1Pacific Institute for Research & Evaluation, Columbia, MD, USA, 2Pacific Institute for Research &
Evaluation, Newcastle, WA, USA
OBJECTIVES: To comprehensively search for SF-12 utility scorings and for EQ-5d
scorings that can be applied to SF-12 data converted to EQ-5d responses using
Gray’s (2006) algorithm. To apply quality/dominance criteria to the identified scor-
ings, apply the scorings of good quality to 3 large US data sets that used the SF12,
and examine the implications for scoring strategy. METHODS: A Medline search
and hand search of selected journals and of reference lists in relevant articles
yielded 27 EQ-5d scorings and 18 studies that provided 29 SF12/SF36 scorings.
Quality/dominance criteria excluded 16 scorings from 8 studies. Data sets scored
included a survey of 21,564 disabled veterans, a national probability sample of
20,048 veterans, and a longitudinal survey with 4,600 responses from 1,547 hospi-
tal-admitted burn victims. We averaged subsets of scores, weighting each compo-
nent score by the number of people polled in the utility weighting exercise.We also
scored 5 extreme value cases.RESULTS:The composite score performed quitewell.
Its values and distribution were similar to those in Sengupta’s Health Utility Index
3 scoring and Lawrence’s scoring derived from SF-12 domain scores. Much has
beenmade of the Shaw article that purportedly shows that EQ-5d scoring needs to
be country specific. That article used a different scoring equation than other EQ-5d
scorings. Its scores differ as much from 4 other US scorings as from overseas scor-
ings – and the other US scores are concordant with the overseas scores. The Gray
algorithm performed extremely well, especially when supplemented by questions
on use of mobility aids. SF-12 scorings are less dispersed and more prone to floor
and ceiling effects than EQ-5d scorings. Time-tradeoff EQ-5d scorings have higher
variance than visual-analog scorings. CONCLUSIONS: Some scorings are better
than others, with Sengupta or Lawrence recommended. Country of origin rarely
matters, with some possible exceptions (Hispanic, African American).
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CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE
PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS: THE CALIPSO
QUESTIONNAIRE
Sampogna F1, Styles I2, Tabolli S1, Abeni D1
1Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy, 2The University of Western
Australia, Perth, Australia
OBJECTIVES:To create a new instrument to evaluate quality of life (QoL) in patients
with psoriasis, fromfive preexistent instruments, using Rasch analysis.METHODS:
ARasch analysis was performed on five QoL instruments, in a group of 936 patients
with psoriasis, recruited in a dermatological hospital. Two instruments were der-
matology-specific [Skindex-29 and Dermatology Life Quality Index (DLQI)], and
three were psoriasis-specific [Psoriasis Disability Index (PDI), Psoriasis Life Stress
Inventory (PLSI), and Impact of Psoriasis questionnaire (IPSO)]. The total number of
itemswas 85. Thenumber of categorieswas reduced to three in each instrument on
the basis of threshold probability curves. Having identified threshold and item
performance for each scale separately, items from all five scales were analyzed
together. Itemswere eliminated on the basis of poor fit to themodel, dependencies
amongst items, item location and qualitative meaning of the items, with the over-
all goals of obtaining a uniform and wide spread of the items as possible, and a
balance among the different subscales. RESULTS: We obtained a final question-
naire of 30 items: 4 symptom, 9 emotion, 10 functioning, and 7 social items. Fifteen
out of 29 items came from the Skindex-29, 8 from the PLSI, 3 from the IPSO, 2 from
the DLQI, and 2 from the PDI. The fit of these items to the Rasch model was satis-
factory. The final Person Separation Index (PSI) was 0.916. CONCLUSIONS: The
advantages of this new instrument are that data for it fit the Raschmodel, and that
it summarizes information from five questionnaires (i.e., 85 items) with just 30
items. Moreover, the 30-item questionnaire is working better than the five instru-
ments together, as the properties we analyzed show. The new instrument will be
validated on a new sample of 300 patients with psoriasis.
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METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC
REVIEW AND ANALYSIS
Perampaladas K, Doble BM, Xie F
McMaster University, Hamilton, ON, Canada
OBJECTIVES: The EQ-5D is one of the most widely used instruments to estimate
utility values. The scoring system of the EQ-5D were developed from valuation
studies, which estimate a scoring function for all EQ-5D health states based on the
general population’s preference for a subset of health states. Due to the wide
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spread use of the EQ-5D a number of country-specific scoring systems have been
developed. The objective of this study was to identify and compare all existing
EQ-5D valuation studies and country-specific scoring systems.METHODS:An elec-
tronic search of MEDLINE, EMBASE, NHS EED, HEED and a search through the past
proceedings of the Euroqol group up to September of 2010 was conducted to iden-
tify all EQ-5D preference elicitation studies. The review included a summary and
comparison of study design, model estimation, study demographics and scoring
function. RESULTS: After screening 2940 citations identified from the literature
search, 33 elicitation studies that contained a unique scoring systemwere included
for final review. The key areas of divergence between the studies include: differ-
ences in methodology used to directly value health (i.e. SG, TTO, etc.), the number
of health states that were directly valued, the transformation of the directly valued
health states, the statistical methods used to derive the scoring system, and the
model variables included in the scoring system. CONCLUSIONS: Differences in
methods do exist between population studies. Knowing the extent, at which the
identified methodological differences can explain the variation, will help deter-
mine whether a global preference for health exists.
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RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D
VALUATIONS
Bailey H1, La Foucade A1, Kind P2
1The University of the West Indies, St. Augustine, Trinidad and Tobago, 2University of York,
York, UK
OBJECTIVES: TheMVH protocol uses a valuation subset of 43 EQ-5D states. Smaller
valuation subsets would allow smaller samples if all respondents can value one set
of states. This study tests the performance of valuation subsets based on orthogo-
nal experiment designs. VAS values obtained for EQ-5D states are affected by the
identity of adjacent states in the elicitation. This study also tests a VAS protocol
developed to minimize such effects. METHODS: 230 respondents were each ran-
domly assigned to one of two orthogonal EQ-5D valuation subsets. EQ-5D states
were printed on 9cm x 4cm cards with rhomboid edges. Respondents first ranked a
shuffled deck of 23 cards. A 1 meter VAS was then placed next to the ranked cards.
Respondents transferred the cards on to the VASwith the rhomboid edges pointing
to the respective values. They could see all of the cards in place at the same time.
Ties were permitted and respondents were free to change the order of states in
moving the cards from the ranked order to the VAS. RESULTS: OLS regression of
VAS Scores produced internally valid models for both valuation subsets with r2 of
0.54 and 0.56. Within sample comparisons of model versus observed VAS values
produced residuals of MAD 3% with individual values crossing 6 VAS points in
only 2 cases. Rank correlation coefficients between model and observed states
0.996. Comparisons across the two subsets/subgroups produced residuals of
MAD4 VAS points and rank correlation coefficients of 0.98 and 0.96.
CONCLUSIONS: This study suggests that orthogonal experiment designs may be
suitable as the basis for the construction of EQ-5D valuation subsets, which can
allow for smaller respondent samples. The statistical properties of the models
arising in this study suggest that some concerns with VAS methods for EQ-5D
elicitations may be reduced using this protocol.
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VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN
VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEW
Chan EKH1, Darmawanti I2, Mulyana OP2, Zumbo BD1
1University of British Columbia, Vancouver, BC, Canada, 2State University of Surabaya,
Surabaya, East Java, Indonesia
OBJECTIVES: Patient-reported outcome (PRO), health-related quality of life
(HRQOL), and related instruments are increasingly used in outcomes research. In
developing and evaluating PRO, HRQOL, and related instruments, measurement
validity is a fundamental consideration. With an eye toward investigating the
methodology of validity and uses of validation, we systematically reviewed the
reporting of validation practice in papers published in Value in Health, the Inter-
national Society for Pharmacoeconomics and Outcomes Research (ISPOR) official
journal. METHODS: A systematic search using the journal official website was
conducted inDecember 2010 – including papers since its inception (January 1998) to
December 2010. Two searches were independently conducted by two of the au-
thors. Keywords used in the search included “development OR measurement OR
psychometric OR psychometrics OR valid OR validation OR validity.” We searched
both the titles (126 citations) and abstracts (347 citations). Papers reporting empir-
ical results on validitywere included. Econometric, opinion, and conference papers
were excluded. A coding sheet was developed and each article was double-coded
independently by at least two of the authors. RESULTS: Ninety-three articles met
the inclusion criteria. The percentage of reports of the broad categories of validity
evidencewere: construct (39.8%), discriminant (28.0%), convergent (26.9%), content
(17.2%), concurrent (14.0%), predictive (5.4%), response processes (4.3%), and con-
sequences (1.1%). A paper may report more than one type of validity evidence. In
addition, 95.7% of the papers referred to the validity of the instrument, rather than
the modern view of validity of the inferences from the scores. CONCLUSIONS:
Findings reveal that validity information is not routinely presented from amodern
validity perspective; that is, consider a unitary view of validity, cite recent theoret-
ical papers in validity theory, or distinguish between validity (as a property) and
validation (as a process/method). Some sources of validity evidence (e.g., conse-
quences and response processes) are essentially ignored.
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TAKE TIME TO TRAIN: EVIDENCE TO SHOW THAT PATIENT TRAINING IN
ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIAL
Ross J1, Ross E1, O’Gorman HJ2, Peck R1
1Almac Clinical Technologies, Souderton, PA, USA, 2Almac Group, Craigavon, UK
OBJECTIVES: To establish the concept that it is best practice to provide training to
patients on how to utilize electronic patient reported outcome (ePRO) systems
before patients begins study participation. METHODS: Methods on how to ap-
proach training patients on ePRO systemswill be presented and recommendations
will be discussed. To provide supporting evidence and information on best prac-
tices used in ePRO, a literature review was conducted to identify articles reporting
on studies that utilized ePRO. Of that, articles were identified that reported provid-
ing training to their patients on the ePRO portion of the study prior to participation.
Rates of ePRO compliance are examined and approaches to training patients are
identified within the articles. RESULTS: Out of the 115 articles identified using
ePRO, 55 (47.8%) reported providing ePRO training to their patients. ePRO compli-
ance rates of studies with patient training were overall high (Mean85.08, Stan-
dard Deviation9.83). Training methods reported included: training session, pro-
viding demonstration, giving instruction, question/answer session, subject
hands-on practice, written instructions/reference material, and testing of mastery
of ePRO tool. Duration of training reported ranged from 1 minute to 4 hours.
CONCLUSIONS: Best practice for training patients is to have a combination of the
methods reported above. Having available a dummy system for training is most
important so that demonstration can be provided, patients can practice using the
system and patients can see exactly what they need to do during their actual study
participation. Questions can be addressed and patients can begin the study with a
clearer understanding of what to do during participation. Training patients allows
for higher comfort levels in use of system, thus alleviating frustration and burden.
Furthermore, when patients are trained, they require less support throughout the
duration of the study. Overall, training patients will lead to better experiences for
patient participation.
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EVALUATING THE SCREENING ABILITY OF PATIENT-REPORTED OUTCOME
INSTRUMENTS
Coon C1, McLeod L1, Arnold L2, Chandran A3, Martin S4
1RTI Health Solutions, Research Triangle Park, NC, USA, 2University of Cincinnati College of
Medicine, Cincinnati, OH, USA, 3Pfizer, Inc., New York, NY, USA, 4RTI Health Solutions, Ann
Arbor, MI, USA
OBJECTIVES:Assessments composed of patient-reported outcome (PRO)measures
can be used in health care settings as screeners for various conditions. The objec-
tive of developing and using a PRO screening measure may be to quickly identify
patients who are likely to benefit from a formal diagnostic evaluation. Alterna-
tively, the development objective may be to avoid unnecessary diagnostic proce-
dures, particularly when these are time or resource-intensive or invasive in nature.
The PRO screener may also be administered to simply rule out the existence of a
particular condition. The evaluation of a PRO screening assessment ideally occurs
through analyses using a “gold standard” diagnosis of the condition of interest.
METHODS: A number of existing statistical and psychometric methods may be
used in such an evaluation, including sensitivity and specificity, positive and neg-
ative predictive value, kappa, accuracy, odds ratio, and likelihood ratio. RESULTS:
The evaluation method selected depends on the objective of the screener itself. If
the formal diagnostic procedures are particularly invasive or time- or resource-
intensive, then screeners should minimize false positives; in contrast, diseases
with exceptional riskswhen left undiagnosed call for screeners thatminimize false
negatives. In this research, we explore these methods using data from a study
comparing various fibromyalgia screening instruments with the currently ac-
cepted gold standard diagnosis for fibromyalgia, namely the American College of
Rheumatology 1990 diagnostic criteria (Wolfe et al., 1990). CONCLUSIONS: Using
the example application, we illustrate the pros and cons of a battery of statistical
methods and how they can be used to select the “best” candidate screener.
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DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT
VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR
TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONS
Mear I1, Conway K2
1MAPI Institute, Lyon, France, 2MAPI Research Trust, Lyon, France
OBJECTIVES: In its guidance on the use of PRO measures, the FDA recommends
that sponsors provide evidence that the content validity and other measurement
properties are adequately similar across all versions used in a clinical trial. One
way to ensure the comparability of content is to ensure that all translations reflect
the original item intent. As this presupposes the existence of a formal description
of each item concept, it is the objective of this study to investigate if this was the
case prior to the guidance publication and to make recommendations on the basis
of our findings.METHODS: The research is based on the review of PRO translations
performed between 1995 and 2009. RESULTS: A total of 640 questionnaires (27
generic and 613 disease- or condition-specific) were translated. All were developed
before the publication of the FDA’s PRO guidance. None had a formal written doc-
ument listing a definition of each item concept and possible translation alterna-
tives available before launching the translations. In all cases, the item-by-item
concept list and the list of translation alternatives were developed in collaboration
with the developers of the original questionnaires during the translation process.
In some cases (multiple projects involving different languages for the same ques-
tionnaire), the development of the concept list was a dynamic process fed by ques-
tions raised at each new translation [e.g. Quality of Life in Inflammatory Bowel
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